Cytokines and acute phase serum proteins as markers of inflammatory regression during the treatment of pulmonary tuberculosis;Citocinas e proteínas de fase aguda do soro como marcadores de regressão da resposta inflamatória ao tratamento da tuberculose pulmonar

Jornal Brasileiro de Pneumologia

Volumn 34, Issue 11, 2008, Pages 942-949

  Peresi, Eliana ^a   Silva, Sônia Maria Usó Ruiz ^b   Calvi, Sueli Aparecida ^a   Marcondes Machado, Jussara ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b INSTITUTO LAURO DE SOUZA LIMA   (Brazil)

Author keywords

Acute phase proteins; Cytokines; Mycobacterium tuberculosis; Tuberculosis therapy

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD; CULTURE TECHNIQUE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; TIME;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CELL CULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; MALE; MIDDLE AGED; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 58849103925     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/S1806-37132008001100009     Document Type: Article

References (30)

1. Raja A. Immunology of tuberculosis. Indian J Med Res. 2004;120(4):213-32.
2. Moreira AL, Tsenova-Berkova L, Wang J, Laochumroonvorapong P, Freeman S, Freedman VH, et al. Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis. Tuberc Lung Dis. 1997;78(1):47-55.
3. Rojas M, Olivier M, Gros P, Barrera LF, García LF. TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. J Immunol. 1999;162(10):6122-31.
4. Toossi Z, Ellner JJ. The role of TGF beta in the pathogenesis of human tuberculosis. Clin Immunol Immunopathol. 1998;87(2):107-14.
5. Numerof RP, Aronson FR, Mier JW. IL-2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cells. J Immunol. 1988;141(12):4250-7.
6. Pinson DM, LeClaire RD, Lorsbach RB, Parmely MJ, Russell SW. Regulation by transforming growth factor-beta 1 of expression and function of the receptor for IFN-gamma on mouse macrophages. J Immunol. 1992;149(6):2028-34.
7. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986;163(5):1037-50.
8. Maeda H, Kuwahara H, Ichimura Y, Ohtsuki M, Kurakata S, Shiraishi A. TGF-β enhances macrophages ability to produce IL-10 in normal and tumor-bearing mice. J Immunol. 1995;155(10):4926-32.
9. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805-12.
10. Santos VM, Cunha SF, Cunha DF. Velocidade de sedimentação das hemácias: utilidade e limitações. Rev Assoc Med Brasil. 2000;46(3):232-6.
11. Agger EM, Andersen P. A novel TB vaccine; towards a strategy based on our understanding of BCG failure. Vaccine. 2002;21(1-2):7-14.
12. Boyum A. Separation of leukocytes from blood and bone marrow. Introduction. Scand J Clin Lab Invest Suppl. 1968;97:7.
13. Morrison DF. Multivariate statistical methods. New York: McGraw-Hill; 1967.
14. Sahiratmadja E, Alisjahbana B, de Boer T, Adnan I, Maya A, Danusantoso H, et al. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun. 2007;75(2):820-9.
15. Suzuki K, Takashima Y, Yamada T, Akiyama J, Yagi K, Kawashima M, et al. The sequential changes of serum acute phase reactants in response to antituberculous chemotherapy [Article in Japanese]. Kekkaku. 1992;67(4):303-11.
16. Sox HC, Liang MH. The erythrocyte sedimentation rate. Guidelines for rational use. Ann Intern Med. 1986;104(4):515-23.
17. Dubost JJ, Soubrier M, Meunie MN, Sauvezie B. From sedimentation rate to inflammation profile [Article in French]. Rev Med Interne. 1994;15(11):727-33.
18. Olobo JO, Geletu M, Demissie A, Eguale T, Hiwot K, Aderaye G, et al. Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts. Scand J Immunol. 2001;53(1):85-91.
19. Portales-Pérez DP, Baranda L, Layseca E, Fierro NA, de la Fuente H, Rosenstein Y, et al. Comparative and prospective study of different immune parameters in healthy subjects at risk for tuberculosis and in tuberculosis patients. Clin Diagn Lab Immunol. 2002;9(2):299-307.
20. Moura EP, Toledo VP, Oliveira MH, Spíndola-de-Miranda S, Andrade HM, Guimarães TM. Pulmonary tuberculosis: evaluation of interferon-gamma levels as an immunological healing marker based on the response to the Bacillus Calmette-Guerin. Mem Inst Oswaldo Cruz. 2004;99(3):283-7.
21. Torres M, Herrera T, Villareal H, Rich EA, Sada E. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect Immun. 1998;66(1):176-80.
22. Turner J, Corrah T, Sabbally S, Whittle H, Dockrell HM. A longitudinal study of in vitro IFNgamma production and cytotoxic T cell responses of tuberculosis patients in the gambia. Tuber Lung Dis. 2000;80(3):161-9.
23. Dlugovitzky D, Bay ML, Rateni L, Fiorenza G, Vietti L, Farroni MA, et al. Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB). Clin Exp Immunol. 2000;122(3):343-9.
24. Verbon A, Juffermans N, Van Deventer SJ, Speelman P, Van Deutekom H, Van Der Poll T. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol. 1999;115(1):110-3.
25. Berktas M, Guducuoglu H, Bozkurt H, Onbasi KT, Kurtoglu MG, Andic S. Change in serum concentrations of interleukin-2 and interferon-gamma during treatment of tuberculosis. J Int Med Res. 2004;32(3):324-30.
26. Deveci F, Akbulut HH, Trugut T, Muz MH. Changes in serum cytokine levels in active tuberculosis with treatment. Mediators Inflamm. 2005;2005(5):256-62.
27. Ellner JJ. Immunosuppression in tuberculosis. Infect Agents Dis. 1996;5(2):62-72.
28. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun. 1995;63(8):3231-4.
29. Fiorenza G, Rateni L, Farroni MA, Bogue C, Dlugovitzky DG. TNF-a, TGF-b and NO relationship in sera from tuberculosis (TB) patients of different severity. Immunol Lett. 2005;98(1):45-8.
30. Hernández-Pando R, Arriaga AK, Panduro CA, Orozco EH, Larriv-Sahd J, Madrid-Marina V. The response of hepatic acute phase response proteins during experimental pulmonary tuberculosis. Exp Mol Pathol. 1998;65(1):25-36.